#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Transferrin decreased Encephalitis autoimmune Pancreatic carcinoma Hodgkin's disease recurrent Barth syndrome Hereditary neuropathic amyloidosis Philadelphia positive acute lymphocytic leukaemia Dedifferentiated liposarcoma Mantle cell lymphoma recurrent Lymphoma Gastric cancer IgA nephropathy Marginal zone lymphoma Follicular lymphoma stage III Staphylococcal infection More trials…

    Learn about Rare Diseases

    Crigler-Najjar syndrome X-linked lymphoproliferative syndrome – Trials in Disease Glomerulonephritis membranous – Life with Disease Niemann-Pick disease – Trials in Disease Ehlers-Danlos syndrome – Treatment Ornithine transcarbamoylase deficiency Activated PI3 kinase delta syndrome – Life with Disease Netherton’s syndrome – Life with Disease Castleman’s disease – Trials in Disease Angelman’s syndrome More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Enfortumab Vedotin Alogliptin BUMETANIDE Loratadine Sulfamethizole ALKYLATING AGENTS Cctx-001 Nvdx3 Ziftomenib Vamorolone Atl001 Chlorphenamine Maleate Emiplacel MARALIXIBAT Resamirigene Bilparvovec Mk-1200 Trastuzumab Deruxtecan A/H1N1 INFLUENZA VACCINE S230815-2 Clotrimazole More therapies…

    Learn about Your Condition

    Clostridium difficile colitis Limb reduction defect Peripheral artery angioplasty Infection Pulmonary embolism Acute cardiac event Cervix carcinoma Naevus flammeus Arterial disorder Acute leukaemia Meningorrhagia Metastases to meninges Thermal burn Factor IX deficiency Soft tissue sarcoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Graalum

  • A study of drug combination (clopidogrel, acetylsalicylic acid, atorvastatin, rosuvastatin) for patients with covert brain infarction

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Clopidogrel
    • Acetylsalicylic Acid
    • Atorvastatin
    Denmark Norway Sweden

  • Study of oral rilzabrutinib for adults with immune thrombocytopenia who did not respond to first-line treatment

    Recruiting

    3 1 1
    Investigated Drugs:
    • Rilzabrutinib
    Austria Czechia France Germany Hungary Italy +3

  • Comparison of Gentamicin with Narrow-Spectrum Antibiotics versus Broad-Spectrum Antibiotics in Adult Patients with Early Sepsis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Sepsis
    Investigated Drugs:
    • Ampicillin Sodium
    • Benzathine Benzylpenicillin
    • BENZYLPENICILLIN POTASSIUM
    Norway

  • Study of vicadrostat and empagliflozin combination in patients with type 2 diabetes, high blood pressure and cardiovascular disease

    Recruiting

    3 1 1
    Investigated Diseases:
    • Cardiovascular disorder
    • Hypertension
    • Type 2 diabetes mellitus
    Investigated Drugs:
    • Bi 690517
    • Empagliflozin
    Austria Belgium Bulgaria Croatia Czechia Denmark +17

  • Study of Mezagitamab in Adults with Primary IgA Nephropathy (Berger’s Disease) to Reduce Protein in Urine

    Recruiting

    3 1
    Austria Czechia France Germany Hungary Italy +6

  • Study on Ferric Derisomaltose for Patients with Iron Deficiency and Chronic Heart Failure

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Cardiac failure chronic
    • Iron deficiency
    Investigated Drugs:
    • Ferric Derisomaltose
    Bulgaria Croatia Czechia Denmark Hungary Latvia +6
Previous Page
1 2 3 4 … 8
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Sodium Chloride Tenecteplase Apixaban Hydrocortisone Clopidogrel Prednisone Alteplase Nivolumab Acetylsalicylic Acid Asundexian Dexamethasone Pembrolizumab Cisplatin Gemcitabine Hydrochloride Dalteparin Sodium Nitrous Oxide Piperacillin Sodium Polatuzumab Vedotin Cortisone Ianalumab Povetacicept Oxygen Prednisolone Tazobactam Sodium Amoxicillin Trihydrate Ketamine Hydrochloride Temozolomide Ferric Derisomaltose Hyoscine Butylbromide Ketamine Show more

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

Acute myocardial infarction Alcohol use disorder Amyotrophic lateral sclerosis Aortic valve stenosis Arteriosclerosis Atrial fibrillation Bladder cancer Cancer pain Cardiac failure chronic Cardiovascular disorder Cerebrovascular accident prophylaxis Chronic kidney disease Chronic obstructive pulmonary disease Cold type haemolytic anaemia Deafness neurosensory Depression Diffuse large B-cell lymphoma refractory Glioblastoma Hormone-refractory prostate cancer Hypertension IgA nephropathy Immune thrombocytopenia Iron deficiency Ischaemic stroke Labour induction Low anterior resection syndrome Lung disorder Major depression Malignant melanoma Metabolic dysfunction-associated steatohepatitis Metastatic neoplasm Migraine Monkeypox Non-alcoholic steatohepatitis Non-small cell lung cancer Non-small cell lung cancer metastatic Pancreatic carcinoma Plasma cell myeloma Pneumonia Primary adrenal insufficiency Pulmonary embolism Renal cell carcinoma Retinal artery occlusion Sepsis Substance use disorder Thrombosis prophylaxis Transient ischaemic attack Transitional cell carcinoma metastatic Type 2 diabetes mellitus Type IIa hyperlipidaemia Warm autoimmune haemolytic anaemia

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!